Adopting CDISC Standards: Our Journey With CDISC
In this case study, we explore our 23-year partnership with CDISC and we look at…
Certara2024年10月8日
To Generate or Not? Where GPTs Are Most Valuable Across Your CSR
GPTsがCSR全体で最も価値を発揮する場面を確認しましょう。
Certara2024年10月7日
Predict Success Faster in Drug Discovery – Designing a More Effective Model for Drug Discovery Research
The average discovery phase of drug development lasts four and half years with just six…
Certara2024年10月2日
Certara Completes Acquisition of Chemaxon
The combined organization offers life sciences companies predictive biosimulation and scientific informatics capabilities, improving certainty…
Certara2024年10月2日
Certara: Bridging Global Expertise with China’s Pharmaceutical Innovation
In a recent BioValley feature, Amin Rostami, CSO & SVP of R&D at Certara, shares…
Certara2024年10月2日
Certara Drug Development & Regulatory Experts Achieve 100th Rare Disease Submission
Dedicated team of global regulatory experts drives the approval of rare disease treatments RADNOR, Pa.…
Certara2024年10月1日
A Quick Guide to SDTM Domains
Our guide is a quick and thorough overview of SDTM domains, to help you implement…
Certara2024年9月30日
A Quick Guide to SDTM Dataset Creation
Our free quick guide can help you better understand SDTM datasets and get started quick…
Certara2024年9月30日
IVIVC Toolkit, How to optimize drug formulation [Korean Webinar]
The bioequivalence (BE) test is a test in which the manufacturer compares the bioavailability of…
Certara2024年9月27日
